
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Calcium Aluminosilicate
Therapeutic Area : Oncology
Study Phase : Undisclosed
Recipient : MD Anderson Cancer Center
Deal Size : Inapplicable
Deal Type : Inapplicable
CASAD for Severe Diarrhea in the Emergency Department
Details : Calcium Aluminosilicate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Neoplasms.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
December 23, 2013
Lead Product(s) : Calcium Aluminosilicate
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Recipient : MD Anderson Cancer Center
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Calcium Aluminosilicate
Therapeutic Area : Gastroenterology
Study Phase : Phase I/ Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
Details : CASAD (Calcium Aluminosilicate) is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Diarrhea.
Product Name : CASAD
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
December 03, 2012
Lead Product(s) : Calcium Aluminosilicate
Therapeutic Area : Gastroenterology
Highest Development Status : Phase I/ Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Calcium Aluminosilicate
Therapeutic Area : Gastroenterology
Study Phase : Phase II
Sponsor : Scott and White Hospital & Clinic | Texas A&M University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Calcium Aluminosilicate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Clostridium Difficile-associated Diarrhea.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
April 04, 2012
Lead Product(s) : Calcium Aluminosilicate
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Sponsor : Scott and White Hospital & Clinic | Texas A&M University
Deal Size : Inapplicable
Deal Type : Inapplicable
